Henry W. Murray
#108,354
Most Influential Person Now
Henry W. Murray's AcademicInfluence.com Rankings
Henry W. Murraybiology Degrees
Biology
#5834
World Rank
#8409
Historical Rank
Microbiology
#239
World Rank
#280
Historical Rank
Immunology
#290
World Rank
#301
Historical Rank
Download Badge
Biology
Henry W. Murray's Degrees
- PhD Immunology Stanford University
- Doctorate Medicine Harvard University
Why Is Henry W. Murray Influential?
(Suggest an Edit or Addition)Henry W. Murray's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity (1983) (1730)
- Advances in leishmaniasis (2005) (1659)
- An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. (1981) (1234)
- Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. (1984) (793)
- Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. (2000) (637)
- The macrophage as an effector cell. (1980) (629)
- Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. (1984) (499)
- Macrophage Microbicidal Mechanisms In Vivo: Reactive Nitrogen versus Oxygen Intermediates in the Killing of Intracellular Visceral Leishmania donovani (1999) (444)
- Interferon-gamma, the activated macrophage, and host defense against microbial challenge. (1988) (426)
- Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. (1983) (374)
- Single-dose liposomal amphotericin B for visceral leishmaniasis in India. (2010) (365)
- Activation of human macrophages. Comparison of other cytokines with interferon-gamma (1984) (363)
- Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. (1985) (345)
- Rapid accurate field diagnosis of Indian visceral leishmaniasis (1998) (281)
- Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy (2002) (268)
- Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates (1979) (248)
- Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis (2001) (236)
- Trial of oral miltefosine for visceral leishmaniasis (1998) (232)
- Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation (1980) (221)
- A Subset of Liver NK T Cells Is Activated during Leishmania donovani Infection by CD1d-bound Lipophosphoglycan (2004) (217)
- The protean manifestations of Mycoplasma pneumoniae infection in adults. (1975) (211)
- Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages (1989) (207)
- Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized controlled trial. (2000) (202)
- Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis (1994) (198)
- Tissue granuloma structure‐function in experimental visceral leishmaniasis (2001) (198)
- Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma. (1987) (197)
- Intracellular Antimicrobial Activity in the Absence of Interferon-γ: Effect of Interleukin-12 in Experimental Visceral Leishmaniasis in Interferon-γ Gene-disrupted Mice (1997) (194)
- New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. (2008) (193)
- Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. (1979) (192)
- An Outbreak of Community-Acquired Pneumocystis Carinii Pneumonia. Initial Manifestation of Cellular Immune Dysfunction (1982) (190)
- L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. (1992) (187)
- Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. (2004) (186)
- Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. (1989) (184)
- Salmonella infections in patients with the acquired immunodeficiency syndrome. (1985) (181)
- Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates (1979) (181)
- Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity. (1983) (178)
- Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial. (2001) (178)
- Regulation of arachidonic acid metabolism by macrophage activation (1982) (176)
- Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production. (1985) (175)
- Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. (1988) (173)
- Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes. (1982) (170)
- Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. (1985) (158)
- Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. (1978) (153)
- Murine Kupffer cells. Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates (1985) (151)
- The dynamics of granuloma formation in experimental visceral leishmaniasis (1988) (149)
- Short-course of oral miltefosine for treatment of visceral leishmaniasis. (2000) (148)
- Splenic cytokine responses in Indian kala-azar before and after treatment. (1998) (148)
- Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. (1997) (146)
- Serious infections caused by Streptococcus milleri. (1978) (146)
- Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. (1988) (144)
- Role and effect of TNF-alpha in experimental visceral leishmaniasis. (1994) (138)
- Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony. (1988) (136)
- Serious infections from Bacillus sp. (1979) (134)
- Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis (1995) (132)
- Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication. (1983) (132)
- Streptococcus bovis bacteremia and underlying gastrointestinal disease. (1978) (131)
- Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. (1982) (130)
- Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. (1992) (130)
- Availability of miltefosine for the treatment of kala-azar in India. (2005) (127)
- Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis. (2000) (125)
- Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis. (1989) (120)
- Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. (1985) (120)
- Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates (1985) (116)
- Role and effect of IL-2 in experimental visceral leishmaniasis. (1993) (115)
- Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment (2000) (114)
- Roles of Endogenous Gamma Interferon and Macrophage Microbicidal Mechanisms in Host Response to Chemotherapy in Experimental Visceral Leishmaniasis (2000) (114)
- Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis (2002) (113)
- Interferon-gamma and host antimicrobial defense: current and future clinical applications. (1994) (113)
- In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes. (1987) (110)
- Oral treatment of visceral leishmaniasis with miltefosine. (1999) (107)
- A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. (1998) (107)
- Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches. (2000) (105)
- Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. (1997) (104)
- Response to interferon-γ plus pentavalent antimony in Indian visceral leishmaniasis (1997) (102)
- Cytomegalovirus retinitis in adults. A manifestation of disseminated viral infection. (1977) (102)
- Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. (2003) (99)
- Short-Course, Low-Dose Amphotericin B Lipid Complex Therapy for Visceral Leishmaniasis Unresponsive to Antimony (1997) (98)
- Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates (1981) (93)
- Patients treated for amebic liver abscess develop cell-mediated immune responses effective in vitro against Entamoeba histolytica. (1986) (93)
- Rapid, Noninvasive Diagnosis of Visceral Leishmaniasis in India: Comparison of Two Immunochromatographic Strip Tests for Detection of Anti-K39 Antibody (2006) (93)
- Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis. (1995) (91)
- Racial and Ethnic Differences in Outcome in Zidovudine-Treated Patients With Advanced HIV Disease (1991) (90)
- Macrophage oxygen-dependent antimicrobial activity. IV. Role of endogenous scavengers of oxygen intermediates (1980) (90)
- Fever, rash, and muscle tenderness. A distinctive clinical presentation of disseminated candidiasis. (1978) (86)
- Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis. (1995) (84)
- Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions. (2007) (83)
- Drugs against leishmaniasis: a synergy of technology and partnerships. (2004) (82)
- Behavior of Visceral Leishmania donovani in an Experimentally Induced T Helper Cell 2 (Th2)-Associated Response Model (1997) (80)
- Lymphokine enhances oxygen-independent activity against intracellular pathogens (1983) (80)
- Treatment of visceral leishmaniasis in 2004. (2004) (79)
- Successful Treatment Of Refractory Visceral Leishmaniasis In India Using Antimony Plus Interferon-ã (1994) (78)
- Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta (1988) (78)
- Antagonizing Deactivating Cytokines To Enhance Host Defense and Chemotherapy in Experimental Visceral Leishmaniasis (2005) (76)
- Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome. (1985) (72)
- Coping with AIDS. The special problems of New York City. (1987) (71)
- Fever and pulmonary thromboembolism. (1979) (70)
- Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma. (1993) (70)
- Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense. In vitro, in animal models, and in humans. (1990) (70)
- Effect of Continuous Administration of Interferon-γ in Experimental Visceral Leishmaniasis (1990) (67)
- Leishmaniasis in the United States: treatment in 2012. (2012) (66)
- Modulation of T-Cell Costimulation as Immunotherapy or Immunochemotherapy in Experimental Visceral Leishmaniasis (2003) (66)
- Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit. (2002) (66)
- Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms. (2000) (64)
- Malaria--the mime revisited: fifteen more years of experience at a New York City teaching hospital. (1992) (63)
- Prevention of Relapse after Chemotherapy in a Chronic Intracellular Infection: Mechanisms in Experimental Visceral Leishmaniasis1 (2005) (62)
- Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex. (1996) (61)
- Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089. (1995) (61)
- Immunoenhancement Combined with Amphotericin B as Treatment for Experimental Visceral Leishmaniasis (2003) (60)
- Kala-azar--progress against a neglected disease. (2002) (59)
- Zidovudine Compared With Didanosine in Patients With Advanced HIV Type I Infection and Little or No Previous Experience With Zidovudine (1995) (58)
- Candida arthritis. A manifestation of disseminated candidiasis. (1976) (58)
- Progress in the treatment of a neglected infectious disease: visceral leishmaniasis (2004) (56)
- Gamma interferon-activated human macrophages and Toxoplasma gondii, Chlamydia psittaci, and Leishmania donovani: antimicrobial role of limiting intracellular iron (1991) (56)
- Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex. (1998) (54)
- Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages. (1986) (53)
- Susceptibility of Entamoeba histolytica to oxygen intermediates. (1981) (53)
- Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine (1993) (53)
- Interferon-γ and Mycobacterium avium-intracellulare Infection (1989) (50)
- The adult respiratory distress syndrome associated with miliary tuberculosis. (1978) (50)
- Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculous mycobacteriosis. (2002) (50)
- Responses to Leishmania donovani in Mice Deficient in Interleukin-12 (IL-12), IL-12/IL-23, or IL-18 (2006) (50)
- Effect of Treatment with Interferon-γ Alone in Visceral Leishmaniasis (1995) (49)
- Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. (1997) (49)
- The role of gamma interferon in the generation of human macrophages cytotoxic for Entamoeba histolytica trophozoites. (1987) (49)
- Current and future clinical applications of interferon-gamma in host antimicrobial defense (1996) (47)
- Antigen-induced human interferon-gamma production. Differential dependence on interleukin 2 and its receptor. (1987) (46)
- Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis. (2000) (45)
- Pulmonary mucormycosis with massive fatal hemoptysis. (1975) (45)
- Mononuclear Cell Recruitment, Granuloma Assembly, and Response to Treatment in Experimental Visceral Leishmaniasis: Intracellular Adhesion Molecule 1-Dependent and -Independent Regulation (2000) (45)
- Accelerated Control of Visceral Leishmania donovani Infection in Interleukin-6-Deficient Mice (2008) (44)
- Effector role of blood monocytes in experimental visceral leishmaniasis (1993) (44)
- Interferon-γ Treatment for Mycobacterium avium-intracellulare Complex Bacillemia in Patients with AIDS (1992) (44)
- Why is Listeria monocytogenes not a pathogen in the acquired immunodeficiency syndrome? (1986) (43)
- Unusual manifestation of tuberculosis: TE fistula. (1976) (43)
- Disseminated paracoccidioidomycosis (South American blastomycosis) in the United States. (1974) (43)
- Pretreatment with phorbol myristate acetate inhibits macrophage activity against intracellular protozoa. (1982) (43)
- T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome. (1988) (42)
- Regulatory Actions of Toll-Like Receptor 2 (TLR2) and TLR4 in Leishmania donovani Infection in the Liver (2013) (42)
- Effect of hydrocortisone on macrophage response to lymphokine (1982) (41)
- Suppression of Posttreatment Recurrence of Experimental Visceral Leishmaniasis in T-Cell-Deficient Mice by Oral Miltefosine (2000) (40)
- Progression to AIDS in patients with lymphadenopathy or AIDS-related complex: reappraisal of risk and predictive factors. (1989) (40)
- Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers (2015) (40)
- Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice. (1995) (39)
- THE PROTEAN MANIFESTATIONS OF MYCOPLASMA PNEUMONIAE INFECTION IN ADULTS (1975) (38)
- Staphylococcal septicemia and disseminated intravascular coagulation. Staphylococcus aureus endocarditis mimicking meningococcemia. (1977) (38)
- Suppression of macrophage antimicrobial activity by a tumor cell product. (1983) (37)
- Kala-azar as an AIDS-related opportunistic infection. (1999) (37)
- IFN-gamma and IFN-alpha induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells. (1989) (36)
- Mycoplasma pneumoniae infection. (1980) (35)
- Treatment of kala-azar with oral fluconazole (1996) (34)
- Circulating Borrelia burgdorferi in patients with acute Lyme disease: results of blood cultures and serum DNA analysis. (1993) (34)
- Fever with dissecting aneurysm of the aorta. (1976) (34)
- Presence of a macrophage-mediated suppressor cell mechanism during cell-mediated immune response in experimental visceral leishmaniasis (1986) (33)
- Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase. (2006) (33)
- Ribavirin pharmacodynamics in high‐risk patients for acquired immunodeficiency syndrome (1987) (33)
- Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis (1996) (32)
- Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy. (1976) (32)
- A novel defect in interferon-gamma secretion in patients with refractory nontuberculous pulmonary mycobacteriosis. (2003) (30)
- Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy (2005) (30)
- The interferons, macrophage activation, and host defense against nonviral pathogens. (1992) (30)
- Models of relapse of experimental visceral leishmaniasis. (1996) (29)
- Visceral Leishmania donovani Infection in Interleukin-13−/− Mice (2006) (29)
- Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune sera (1990) (29)
- Ventriculoatrial shunting for hydrocephalus complicating tuberculous meningitis. (1981) (29)
- Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis. (2005) (28)
- Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia. (1983) (28)
- Mononuclear phagocyte antimicrobial and antitumor activity: the role of oxygen intermediates. (1980) (27)
- Cellular resistance to protozoal infection. (1986) (26)
- Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor. (1996) (26)
- Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma. (1994) (25)
- Leishmania donovani by Lymphokine-stimulated Human Mononuclear Phagocytes EVIDENCE THAT INTERFERON-'y IS THE ACTIVATING LYMPHOKINE (1983) (25)
- Disseminated aspergillosis in a renal transplant patient: Diagnostic difficulties re-emphasized. (1975) (25)
- Non-oral treatment with ivermectin for disseminated strongyloidiasis. (2010) (25)
- Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis. (1990) (24)
- Isolated meningitis caused by Blastoschizomyces capitatus. (1990) (23)
- Macrophage activation: enhanced oxidative and antiprotozoal activity. (1984) (22)
- Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis. (1984) (21)
- Tropical medicine (2000) (21)
- Interferon-gamma treatment for Mycobacterium avium-intracellular complex bacillemia in patients with AIDS. (1992) (21)
- Effect of treatment with interferon-gamma alone in visceral leishmaniasis. (1995) (21)
- Pulmonary mucormycosis: one hundred years later. (1977) (21)
- Response to chemotherapy in experimental visceral leishmaniasis: T cell-dependent but interferon-gamma- and interleukin-2-independent. (1991) (21)
- Cutaneous leishmaniasis in North Dakota. (2014) (20)
- Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis. (1999) (20)
- Bacterial invasion of pulmonary vessels. Pseudomonas bacteremia mimicking pulmonary thromboembolism with infarction. (1978) (19)
- Antimicrobial therapy in pulmonary aspiration. (1979) (19)
- Onchocerciasis in New York City. The Moa-Manhattan connection. (1994) (18)
- Arizona hinshawii osteomyelitis with antecedent enteric fever and sepsis. A case report with a review of the literature. (1976) (18)
- Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis. (1996) (17)
- Blood monocytes: differing effector role in experimental visceral versus cutaneous leishmaniasis. (1994) (17)
- Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice (1990) (17)
- Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India. (2010) (17)
- Delivery of human interferon-gamma via gene transfer in vitro: prolonged expression and induction of macrophage antimicrobial activity. (1996) (17)
- Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver (2016) (16)
- Urinary temperature: a clue to early diagnosis of factitious fever. (1977) (15)
- Therapeutic Effect of Interferon-γ Gene Transfer in Experimental Visceral Leishmaniasis (1998) (15)
- Fuo: Fever of Undetermined Origin (1983) (14)
- T lymphocyte responses to mycobacterial antigen in AIDS patients with disseminated Mycobacterium avium-Mycobacterium intracellulare infection. (1988) (14)
- Survival of intracellular pathogens within human mononuclear phagocytes. (1988) (14)
- Accessory cell function of AIDS monocytes. (1987) (14)
- Drug fever induced by heparin. (1992) (13)
- Circulating interferon gamma in AIDS patients treated with interleukin-2. (1988) (13)
- In vivo killing of intracellular visceral Leishmania donovani by a macrophage-targeted hydrogen peroxide-generating system. (1988) (13)
- Fatal retroperitoneal hemorrhage. An unusual complication of renal cortical abscess. (1979) (12)
- Transient autoimmune hemolytic anemia and pulmonary tuberculosis. (1978) (12)
- Malaria: 30 years of experience at a New York City teaching hospital. (2004) (12)
- Antigen-stimulated human interferon-gamma generation: role of accessory cells and their expressed or secreted products. (1989) (11)
- Macrophage oxygen-dependent killing of intracellular parasites: Toxoplasma and Leishmania. (1983) (11)
- Nafcillin Therapy for Staphylococcus aureus Endocarditis (1978) (11)
- Septic pulmonary embolism complicating a central venous catheter. (1990) (11)
- How protozoa evade intracellular killing. (1983) (11)
- Cytokines as antimicrobial therapy for the T cell-deficient patient: prospects for treatment of nonviral opportunistic infections. (1993) (11)
- Interferon-γ therapy in AIDS for mononuclear phagocyte activation (1990) (10)
- Use of granulocyte-macrophage colony stimulating factor for treatment of drug-induced agranulocytosis. (1991) (10)
- Human immunodeficiency virus infection and bacteremic meningococcal pneumonia. (1991) (10)
- Response to treatment for an intracellular infection in a T cell-deficient host: toxoplasmosis in nude mice. (1993) (10)
- IFN-γ-induced macrophage antileishmanial mechanisms in mice: A role for immunity-related GTPases, Irgm1 and Irgm3, in Leishmania donovani infection in the liver. (2015) (10)
- Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar. (1998) (9)
- Tuberculous meningitis in a puerperal woman. (1980) (9)
- AGONIST AND ANTAGONIST EFFECTS OF INTERFERON a AND # ON ACTIVATION OF HUMAN MACROPHAGES Two Classes of Interferon y Receptors and Blockade of the High-Affinity Sites by Interferon a or (8)
- Macrophage activation in the acquired immunodeficiency syndrome. (1988) (8)
- Fungal cholecystitis and AIDS. (1990) (8)
- Interferon-gamma and Mycobacterium avium-intracellulare infection. (1989) (8)
- Gamma interferon in the treatment of Kala-azar and other forms of Leishmaniasis. (1995) (8)
- Spontaneous bacterial empyema, pericarditis, and peritonitis in cirrhosis. (1977) (8)
- Kala-azar comes to New York. (1997) (8)
- Multiple host defense defects in failure of C57BL/6 ep/ep (pale ear) mice to resolve visceral Leishmania donovani infection (1996) (7)
- Interleukin-2 treatment, interferon-γ induction, and AIDS monocyte activation (1992) (7)
- Interferon-gamma in infection and immunoparalysis (2005) (7)
- Factitious fever updated. (1979) (7)
- Therapeutic effect of interferon-gamma gene transfer in experimental visceral leishmaniasis. (1998) (6)
- The local cellular immune response in experimental leishmaniasis. (1987) (6)
- Colorado tick fever in a resident of New York City. (1994) (5)
- Tropical medicine. Recent advances. (2000) (5)
- Granzyme-Mediated Regulation of Host Defense in the Liver in Experimental Leishmania donovani Infection (2014) (5)
- Quinacrine-induced psychiatric disturbances. (1982) (5)
- Opportunistic infections and impaired cell-mediated immune responses in patients with the acquired immune deficiency syndrome. (1984) (5)
- A Manifestation of Disseminated Viral Infection (1977) (5)
- Lymphocyte proliferation assay in Lyme disease. (1992) (5)
- Case Report: Mucosal Leishmaniasis in New York City. (2020) (4)
- Pseudomonas Bacteremia Mimicking Pulmonary Thromboembolism with Infarction (1978) (4)
- Properties of resident and inflammatory macrophages in mouse liver (1985) (3)
- Lymphokine stimulated macrophages inhibit intracellular Chlamydia psittaci replication by mechanisms distinct from intracellular inhibition of Toxoplasma gondii replication. (1983) (3)
- Pulmonary edema in malaria. (1999) (2)
- Interleukin-2 treatment, interferon-gamma induction, and AIDS monocyte activation. (1992) (2)
- Is the appendix boring? (1981) (2)
- Atypical pneumonias. (1980) (2)
- Fever of undetermined origin. (1979) (2)
- Uveitis and the immunologically compromised host. (1978) (2)
- Appendicitis With Perforation: A Reminder to Internists (1980) (2)
- Not everything that glitters is Lyme disease. (1992) (2)
- The Local T Cell Response in Experimental Leishmaniasis (1989) (2)
- Cardiac Munchausen Syndrome (1974) (2)
- Targeting IL-27 and/or IL-10 in Experimental Murine Visceral Leishmaniasis. (2020) (2)
- Tropical Medicine (1945) (1)
- Cellular immunity and the acquired immune deficiency syndrome: failure to secrete lymphokines and gamma interferon. (1984) (1)
- Interferon-gamma therapy in AIDS for mononuclear phagocyte activation. (1990) (1)
- In vitro granuloma formation in experimental visceral leishmaniasis. (1987) (1)
- A Case Report with a Review of the Literature (1976) (1)
- Costs of Amphotericin B Lipid Complex for Kala-Azar (1998) (1)
- Chiclero's Ulcer. (2020) (1)
- Immunologic developments in AIDS--1985. (1986) (1)
- Combination liposomal amphotericin B (AmBisome (R), AmB) and miltefosine (MF) for the treatment of visceral leishmaniasis (VL) in northern Bihar, India (2007) (1)
- MacroplwKe Actimtion: Eulwuced Oxidatit·e ami Antiprotozoal Acti rit r (1984) (0)
- Suppression ofT-Lymphocyte Responses toEntamoeba histolytica (1990) (0)
- Infeccion pulmonar por aspiracion (1989) (0)
- oplasma activity and oxidative capacity of peritoneal cells stimulated in vivo by inflammatory and immunologic agents, and in vitro by soluble products of sensitized lymphocytes (2003) (0)
- INTERFERON‐GAMMA IN INFECTIOUS DISEASES: CLINICAL APPLICATIONS: 680 (1997) (0)
- The Pretravel Consultation: Recent Updates. (2020) (0)
- Letter: Allergic reactions to amphotericin B. (1974) (0)
- Retinitis: a manifestation of primary or secondary cytomegalovirus infection? (1978) (0)
- Unusual pleocytosis in aseptic meningitis. (1977) (0)
- Rabies Exposures in International Travelers: A Review (2021) (0)
- Secondary peritonitis and intra-abdominal abscess. (1990) (0)
- Fly bites and skin lesion in an asymptomatic traveler returned from Tanzania: Next steps? (2022) (0)
- SEPTIC BURSITIS (1978) (0)
- Letter: "Goalpost fever". (1975) (0)
- The kinetoplast in the diagnosis of visceral leishmaniasis (2022) (0)
- Leishmaniasis Therapy in 2008 (2008) (0)
- Roentgenographically Atypical Pneumocystis carinii Pneumonia (2015) (0)
- Immunologic developments in AIDS--1984. (1985) (0)
- Letter: Cardiac Munchausen syndrome. (1974) (0)
- Pulmonary Mucormycosis with Massive Fatal (2015) (0)
- Mechanisms in Experimental Visceral a Chronic Intracellular Infection: Prevention of Relapse after Chemotherapy in (2005) (0)
- Colovesical fistula. (1979) (0)
- Letter: Roentgenographically atypical Pneumocystis carinii pneumonia. (1975) (0)
- Update in Antiparasitic Therapy (2008) (0)
- Monocytes in HIV infection. (1989) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Henry W. Murray?
Henry W. Murray is affiliated with the following schools:
